Fermenta Biotech Ltd reports Q2FY27 revenue of ₹135.8 crore, EBITDA of ₹23.2 crore and PAT of ₹9.4 crore
- Revenue was flat year on year and up 8% sequentially; EBITDA fell 28% year on year, with a 17.1% margin.
- H1FY27 revenue declined 7% to ₹261.9 crore, EBITDA fell 34% to ₹45.6 crore and PAT declined 52% to ₹18.9 crore.
- Year-on-year declines were attributed mainly to lower animal nutrition business and a prior-year comparison that included insurance income, real estate value unlocking and FX gains.
